Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Participation in NAMA

19 Jul 2010 16:27

RNS Number : 5754P
Bank of Ireland(Governor&Co)
19 July 2010
 



NAMA19 July 2010

 

Update on Bank of Ireland Group's Participation in the National Asset Management Agency ("NAMA")

 

Bank of Ireland Group has completed and submitted to NAMA all of the due diligence material in respect of its Tranche 2 loans and associated derivatives amounting to €2.3bn in nominal value. These loans comprise €1.1bn of land and development loans and €1.2bn of associated loans. The nominal value of the consideration to be received for these loans is expected to be approximately €1.5bn resulting in an estimated discount to gross book value (before impairment provisions) on these loans of approximately 34.9%.

 

As at 19 July 2010, Bank of Ireland Group has transferred €1.8bn (before impairment provisions) of these Tranche 2 loans to NAMA, comprising €1.0bn land and development loans and €0.8bn associated loans. The nominal value of the consideration received for these loans transferred amounted to €1.1bn in Government guaranteed bonds and non-guaranteed subordinated bonds resulting in a gross loss on book value of approximately €0.7bn1 and an estimated discount to gross book value on these loans of approximately 38.5%. The remaining Tranche 2 loans, which predominantly comprise associated loans, are expected to transfer to NAMA in due course.

 

As previously advised, the gross loss on disposal of Bank of Ireland Group Eligible Bank Assets to NAMA will be a function of three factors: the quantum of those loans, the mix of those loans, as between land and development and associated loans, and the discount that would apply to those loans. The Group announced on 26 April 2010 that it believed that the discount on the total portfolio of €12.2bn expected to transfer to NAMA would be within the guidance of €4.8bn (before impairment provisions of €2.8bn at 31 December 2009) provided at the Extraordinary General Court of the Bank on 12 January 2010. The Group made this statement on the basis of the discount arising on Tranche 1 coupled with the results of a valuation exercise on a sample of €6.0bn (approximately 50% of the loans which the Group expects to transfer to NAMA). On the basis of the results of Tranche 1 and the anticipated results of Tranche 2 outlined above, the Group does not expect any material difference to the position announced on 26 April 2010.

 

However, as previously advised, significant uncertainties still remain as to the final discount which will be applicable to Bank of Ireland Group. The Group will only be able to accurately quantify the ultimate gross loss on the transfer of all the Bank of Ireland Eligible Bank Assets to NAMA on completion of the relevant due diligence and the transfer of all the loans to NAMA.

 

1 Prior to (i) any impairment previously recognised by the Group, (ii) the fair value adjustments in respect of any consideration received, (iii) any provision that may be required under accounting standards due to the ongoing cost of servicing these assets on behalf of NAMA, and (iv) taking account of the costs of the transfer.

 

For further information, please contact:

John O'Donovan

Group Chief Financial Officer

+353 (0) 76 623 4703

Andrew Keating

Director of Group Finance

+353 (0) 1 637 8141

Dan Loughrey

Head of Group Corporate Communications

+353 (0) 76 623 4770

 

 

Forward Looking Statement

This document contains certain forward looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the Group) plans and its current goals and expectations relating to its future financial condition and performance and the markets in which it operates. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', or other words of similar meaning. Examples of forward looking statements include among others, statements regarding the Group's future financial position, income growth, business strategy, projected costs, projected impairment losses, capital ratios, margins, future payment of dividends, the outcome of the current review of the Group's defined benefit pension schemes, estimates of capital expenditures, discussions with Irish, European and other regulators and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties relating to the performance of the Irish and UK economies, property market conditions in Ireland and the UK, costs of funding, the performance and volatility of international capital markets, the expected level of credit defaults, the impact of the National Asset Management Agency, the Group's ability to expand certain of its activities, development and implementation of the Group's strategy, including the ability to achieve estimated cost reductions, competition, the Group's ability to address information technology issues, and the availability of funding sources. Any forward looking statements speak only as at the date they are made. The Group does not undertake to release publicly any revision to these forward looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKUVRROABAAR
Date   Source Headline
12th Jul 20102:39 pmRNSBlocklisting Interim Review
8th Jul 20105:00 pmRNSDirectorate Change - Appointment of a New Director
18th Jun 20103:53 pmRNSPillar 3 Disclosures 31 December 2009
16th Jun 20105:01 pmRNSNotification Of Major Interest in Shares
15th Jun 20107:00 amRNSFiling of Form 20-F
14th Jun 201010:07 amRNSTotal Voting Rights
14th Jun 20107:00 amRNSMain Securities Market Notice
11th Jun 20105:00 pmRNSMSM - Cancellation Notice
11th Jun 20103:06 pmRNSNotice of Redemption and Change of Maturity Dates
9th Jun 20106:16 pmRNSDirector/PDMR Shareholding
9th Jun 201011:28 amRNSCompletion of Rights Issue - Non US
9th Jun 20107:00 amRNSRights Issue Take Up - US
9th Jun 20107:00 amRNSRights Issue Take up - Non US
9th Jun 20107:00 amRNSDebt Equity Exchange Final Tender Results
8th Jun 201011:00 amRNSMSM - Cancellation Notice
4th Jun 20105:06 pmRNSDirector/PDMR Shareholding
26th May 20104:12 pmRNSDirector/PDMR Shareholding
25th May 20104:39 pmRNSNotification of Major Interest in Shares
24th May 20102:10 pmRNSNotification of Major Interests in Shares
21st May 20107:00 amRNSTotal Voting Rights
20th May 20108:56 amRNSDebt Equity Minimum Conversion Price - US
20th May 20108:56 amRNSDebt Equity Minimum Conversion Price - Non US
20th May 20108:56 amRNSAdmission of Stock to official lists
20th May 20107:00 amRNSDirectorate Change
20th May 20107:00 amRNSResolutions Passed at Annual General Court
20th May 20107:00 amRNSMain Securities Market Notice
19th May 20105:53 pmRNSProvisional Allotment Letter + Rights Issue Guide
19th May 20103:31 pmRNSResolutions Passed at Extraordinary General Court
17th May 20105:46 pmRNSCall Option
17th May 20108:25 amRNSUS Exchange Offer Rights Issue
17th May 20107:00 amRNSNON US Exchange Offers Rights Issue Terms Ann
17th May 20107:00 amRNSAnnouncement of Rights Issue Terms
13th May 20106:13 pmRNSAnnual Information Update
10th May 20106:13 pmRNSNotification of major interest in shares
10th May 201011:55 amRNSEarly Tender Results in Exchange Offer
10th May 201011:55 amRNSResults Announcement - Non US Offer
10th May 201011:55 amRNSCapital Raising Update
27th Apr 20103:58 pmRNSNotification of Major Interests in Shares
27th Apr 20107:00 amRNSMain Market Notice
26th Apr 20104:30 pmRNSDocuments available for Inspection - AGC
26th Apr 20104:11 pmRNSPublication of Prospectus and Circular
26th Apr 20107:00 amRNSDebt Equity Exchange - US
26th Apr 20107:00 amRNSCapital Raising Announcement - US
26th Apr 20107:00 amRNSCapital Raising Announcement - Non US
26th Apr 20107:00 amRNSInterim Management Statement
26th Apr 20107:00 amRNSDebt Equity Exchange - European
23rd Apr 20104:54 pmRNSCall Option
23rd Apr 20104:51 pmRNSMajor Interest in Shares
22nd Apr 20107:00 amRNSUpdate on Capital Assessment Review
16th Apr 20106:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.